tirzepatide · Powder

What changed in the last 90 days

Every detected change for tirzepatide, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in GLP-1 Receptor Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• liraglutide· in shortage
• insulin degludec and liraglutide· 1 maker
• insulin glargine and lixisenatide· 1 maker
• oral semaglutide· 1 maker
• dulaglutide· 6 makers
• orforglipron· 7 makers
• exenatide· 9 makers
• semaglutide· 48 makers

Common questions

Is Tirzepatide in shortage right now?

No. FDA does not currently list Tirzepatide in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Tirzepatide?

38 companies have marketed Tirzepatide in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Tirzepatide cost?

The typical pharmacy pays about $525.78 per mL, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.